U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Over-the-Counter (OTC) Drugs
  6. Status of OTC Rulemakings
  7. Rulemaking History for OTC Menstrual Drug Products
  1. Status of OTC Rulemakings

Rulemaking History for OTC Menstrual Drug Products

Pending Final Monograph (21 CFR part 357 subpart K):  
Miscellaneous Internal Drug Products for Over-the-Counter Human Use

FDA Archive-It webpage:

Search for Federal Register documents:

OTC Menstrual Drug Products found on this page:

Menstrual Drug Products: Original Active Ingredients and Labeling

Advance Notice Of Proposed RulemakingDateFR Citation
Advance Notice Of Proposed Rulemaking12/7/198247FR55076
   Correction1/14/198348FR1758
    Correction2/18/198348FR7202
Proposed RuleDateFR Citation
Tentative Final Monograph11/16/198853FR46194
   Correction1/18/198954FR2039
Proposed Rule: Classifies category II and III ingredients without data as nonmonograph8/25/199257FR38568
    Correction9/8/199257FR40944
    Technical Amendment: Correct an ingredient name10/1/199257FR45295disclaimer icon
    Correction11/9/199257FR53300
Final RuleDateFR Citation
Final Rule: Classifies category II and III ingredients without data as nonmonograph5/10/199358FR27636

Menstrual Drug Products: Nonmonograph Ingredients

Proposed RuleDateFR Citation
Proposed Rule: Classifies category II and III ingredients without data as nonmonograph8/25/199257FR38568
    Correction9/8/199257FR40944
    Technical Amendment: Correct an ingredient name10/1/199257FR45295
    Correction11/9/199257FR53300
Final RuleDateFR Citation
Final Rule: Classifies category II and III ingredients without data as nonmonograph5/10/199358FR27636